Specific treatment of Chagas disease: current status and new developments.
about
The molecular analysis of Trypanosoma cruzi metallocarboxypeptidase 1 provides insight into fold and substrate specificityAmerican trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategiesNeuroparasitic Infections: Cestodes, Trematodes, and ProtozoansTwo approaches to discovering and developing new drugs for Chagas disease.Secondary loss of chloroplasts in trypanosomesDrug strategies targeting CYP51 in neglected tropical diseasesVaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionChemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi.Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruziSterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.CYP51: A major drug target in the cytochrome P450 superfamilyDesign, synthesis and biological evaluation of WC-9 analogs as antiparasitic agentsUsefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations.Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agentsPharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.Molecular dynamics simulations of peptide inhibitors complexed with Trypanosoma cruzi trypanothione reductase.Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease.Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotateGenotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazoleExperimental and Clinical Treatment of Chagas Disease: A Review.Trypanosoma cruzi: Evaluation of PCR as a Laboratory Tool to Follow up the Evolution of Parasite Load.
P2860
Q27652153-88C20F30-B70A-4DC3-BD1B-D0E6B7A6F9D0Q28182408-9142C515-9243-4D86-A15E-4016F3C36B6DQ29039907-3232831B-DE86-4540-B71E-F5309AD6A79DQ33503274-2A08D13D-A4B0-4ED1-A2E0-FE661D1F6B99Q34327464-C42A345C-94D4-486A-AEA4-21451BFD360AQ34622554-3205942A-0576-4873-B1DB-B35B2FBE4E51Q34700649-8A075E9B-3B9D-4CB2-AEC1-8DEAE84B7CEDQ34724956-E942157A-7B6D-474C-9494-ADDE5EEE93B4Q35011455-48E4EB19-4899-4580-A9C2-1C356EC98DACQ35125554-6A52F54F-82F2-4B04-8919-9854E0782443Q35883877-AB750F3B-BF56-40D8-B292-9BD0AAF37CD6Q36018865-C46443D1-77ED-4C54-A562-E49C13D8B3D5Q36094866-791AB460-9A8A-4B3F-B658-D486419276DAQ36572552-9FFF031D-1430-4011-AB41-EAD343952D37Q37273355-460D6187-4315-4FAD-BCBC-0A2347E87954Q37318751-E10A020E-E329-4219-A0A3-B1BE4A35CF1FQ37597052-38ACC8CF-4393-4734-B6E4-9A493399EC9EQ38920814-C8FE084F-B60C-479D-AE1C-35AE72133CBDQ39350243-2CD49738-428F-4184-97EB-B987155B0353Q39462850-75A0180A-D376-44A6-9B43-F90DB3A48B38Q39755589-E5856D3B-662E-494A-8593-9E98C1400316Q41542876-349C9579-43E4-4353-AB6C-36937C1B480AQ41911754-37E28E9E-2FFC-4860-BDB1-F193AA13267DQ41989175-D913A5B1-937E-4026-B63C-97392B6E93B0Q42328627-DE0A9E24-E51F-4653-BC97-96C4189332D1
P2860
Specific treatment of Chagas disease: current status and new developments.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Specific treatment of Chagas disease: current status and new developments.
@ast
Specific treatment of Chagas disease: current status and new developments.
@en
Specific treatment of Chagas disease: current status and new developments.
@nl
type
label
Specific treatment of Chagas disease: current status and new developments.
@ast
Specific treatment of Chagas disease: current status and new developments.
@en
Specific treatment of Chagas disease: current status and new developments.
@nl
prefLabel
Specific treatment of Chagas disease: current status and new developments.
@ast
Specific treatment of Chagas disease: current status and new developments.
@en
Specific treatment of Chagas disease: current status and new developments.
@nl
P1476
Specific treatment of Chagas disease: current status and new developments.
@en
P2093
P304
P356
10.1097/00001432-200112000-00012
P577
2001-12-01T00:00:00Z